News

Filter

Current filters:

None

8011 to 8020 of 97249 results

Actelion hikes earnings outlook despite lower sales

20-07-2012

Switzerland-based Actelion (ATLN: VX), Europe's largest biotech company, reported first-half 2012 financial…

ActelionBiotechnologyFinancial

Dr Reddy's posts 28% revenue growth for fiscal 1st-qtr 2013

20-07-2012

India's second largest drugmaker Dr Reddy's Laboratories (NYSE: RDY) yesterday released unaudited consolidated…

Dr Reddy's LaboratoriesFinancialGenerics

Pharmaceutical supply chain in Japan sees squeezed margins

19-07-2012

Pressures felt in Japan as a result of the country's aging population, drug price revisions and patent…

Asia-PacificBiotechnologyFinancialMarkets & MarketingMergers & AcquisitionsPharmaceuticalPricing

Domestic HIV funding outpaces international investments

19-07-2012

A new report by the Joint United Nations Program on HIV/AIDS (UNAIDS) shows that domestic funding for…

Anti-viralsFinancialGlobalHealthcarePharmaceutical

Alimera's Iluvien approved in France for diabetic macular edema

19-07-2012

USA-based ophthalmic biopharma specialist Alimera Sciences (Nasdaq: ALIM) says that French regulator…

Alimera SciencesEuropeFinancialIluvienOphthalmicsPharmaceuticalRegulation

SYGNIS and GENETRIX to combine subsidiary X-Pol business

19-07-2012

German biotech firms SYGNIS Pharma AG (Frankfurt: LIOK) and GENETRIX have signed a binding term sheet…

BiotechnologyGENETRIXMergers & AcquisitionsQualiphiSYGNIS Pharma

Lithuania and Poland negotiate joint drug packaging agreement

19-07-2012

In a high level meeting, government officials from Lithuania and Poland explored the possibility to legalize…

EuropePharmaceuticalRegulation

Novartis beats forecasts, despite generic and currency hits

19-07-2012

Second-quarter 2012 group net sales at Swiss drug major Novartis (NOVN: VX) came in at of $14.3 billion,…

AlconFinancialGenericsNovartisPharmaceuticalSandoz

8011 to 8020 of 97249 results

Back to top